Factors that predict the successful eradication when treating H. pylori infection: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sargun Walia (talk | contribs) No edit summary |
||
Line 12: | Line 12: | ||
side-effects and the sensitivity of the [[H. pylori]] strain to the combination of [[antibiotics]] administered. | side-effects and the sensitivity of the [[H. pylori]] strain to the combination of [[antibiotics]] administered. | ||
|- | |- | ||
|}<ref name="urlwww.nature.com2">{{cite web |url=https://www.nature.com/ajg/journal/v112/n2/pdf/ajg2016563a.pdf |title=www.nature.com |format= |work= |accessdate=}}</ref> | |||
|} | ==References== | ||
{{reflist|2}} |
Revision as of 20:32, 12 December 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2], Sargun Singh Walia M.B.B.S.[3]
2017 ACG Guidelines for factors that predict the successful eradication when treating H. pylori infection
Conditional recommendation |
1.The main determinants of successful H. pylori eradication are the choice of the regimen, the patient’s adherence to a multi-drug regimen with frequent
side-effects and the sensitivity of the H. pylori strain to the combination of antibiotics administered. |
References
- ↑ "www.nature.com" (PDF).